Barclays PLC Increases Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Barclays PLC grew its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 9.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 142,914 shares of the biopharmaceutical company’s stock after buying an additional 12,533 shares during the period. Barclays PLC […]
Barclays PLC grew its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 9.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 142,914 shares of the biopharmaceutical company’s stock after buying an additional 12,533 shares during the period. Barclays PLC […]
